If it’s up to some pharmaceutical companies, in some countries the vitamin B3 analog nicotinamide mononucleotide (NMN) may soon no longer be available as a supplement, but as an undoubtedly expensive drug that reduces aging symptoms and extends life. We doubt whether the companies in question will succeed in this aim. But when it comes […]